RECRO PHARMA INC's ticker is REPH and the CUSIP is 75629F109. A total of 89 filers reported holding RECRO PHARMA INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2020 | $645,000 | -58.2% | 78,887 | -6.3% | 0.20% | -31.5% |
Q4 2019 | $1,544,000 | +49.3% | 84,219 | -9.7% | 0.29% | +27.9% |
Q3 2019 | $1,034,000 | +103300.0% | 93,310 | +92286.1% | 0.23% | – |
Q4 2016 | $1,000 | 0.0% | 101 | 0.0% | 0.00% | – |
Q3 2016 | $1,000 | 0.0% | 101 | 0.0% | 0.00% | – |
Q2 2016 | $1,000 | 0.0% | 101 | 0.0% | 0.00% | – |
Q1 2016 | $1,000 | – | 101 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Samjo Capital LLC | 8,039,100 | $3,770,338 | 1.48% |
First Light Asset Management, LLC | 19,676,396 | $9,228,230 | 0.88% |
AWM Investment Company, Inc. | 10,266,144 | $4,814,822 | 0.71% |
Caligan Partners LP | 1,689,768 | $794,191 | 0.36% |
HighMark Wealth Management LLC | 484,985 | $227,458 | 0.19% |
Nantahala Capital Management | 1,250,000 | $586,250 | 0.05% |
Clear Harbor Asset Management, LLC | 938,847 | $440,319 | 0.05% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 4,249,229 | $1,992,888 | 0.03% |
TITLEIST ASSET MANAGEMENT, LLC | 210,148 | $98,559 | 0.02% |
ROYCE & ASSOCIATES LP | 3,285,082 | $1,540,703 | 0.02% |